Prevalence of Organ Failure Identified as Major Accelerators to the Organ Transplantation Market
Organ transplantation is the removal of organ or tissue from one individual and its placement in another. Organ transplantation can also be performed within the same individual, as tissues can be moved to a different location within the same body. Organ transplantation has become a major tool for the healthcare sector in recent decades, with organ transplantation providing a solution to many notable and concerning health issues such as nephritis and terminal heart conditions. Organ transplantation is a triumph of modern medicine and must be celebrated as one of the most ingenious solutions ever developed in the healthcare sector.
The Global Organ Transplantation Market, as per the study conducted by Market Research Future (MRFR), is expected to attain a compound annual growth rate of 9.8% during the forecast period of 2018 to 2023. An increasing number of organ transplantation surgeries undertaken globally is one of the major drivers of the organ transplantation market. Increasing prevalence of chronic diseases, advancements in technology, changing lifestyle of individuals, and the rising aging population are some of the other key factors influencing the growth of the global market.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/915
However, at the same time, it is worth noting that the high treatment cost and increasing incidences of organ failure can severely hamper the projected growth of the market.
Organ Transplantation Market Leaders
- TransMedic, Inc. (US),
- Transonic (US),
- Novartis International AG (Switzerland),
- OrganOX Limited (UK),
- F. Hoffmann-La Roche Ltd. (Switzerland),
- Terumo Medical Corporation (US),
- Preservation Solutions, Inc. (US),
- Transplant Biomedical (UK),
- Accord Healthcare GmbH (Spain),
- Astellas Pharma, Inc (Japan),
- Pfizer, Inc. (US),
- Veloxis Pharmaceuticals A/S (Denmark),
- Bio Med Pvt. Ltd. (US),
- GlaxoSmithKline Plc. (UK),
- Sanofi (France)
Organ Transplantation Market Growth and Share Analysis by Regions
The regional segmentation of the organ transplantation market covers the following regions: Europe, Americas, Asia Pacific, and the Middle East and Africa.
America holds the largest share of the market in the global standings of organ transplantation. This is due to the increasing prevalence of chronic diseases. Other key factors influencing the growth of the market in this region are the rising aging population, an increase in the number of organ transplantation cases, and striking developments in technology.
Europe stands second in the global organ transplantation market due to various essential factors or drivers. The regional market is driven by the developed infrastructure, encouragement for the emergence of new organizations, and increasing expenditures on healthcare.
Asia Pacific is expected to grow at a notable pace in the near future and cement its position as one of the key regions in the global organ transplantation market. Factors such as fast-paced development in the healthcare industry, presence of a huge patient population pool, and the availability of skilled professionals are the major growth drivers of the market. However, in the Middle East and Africa region, the poor economical condition coupled with the limited growth of the healthcare sector is expected to be responsible for the meagre growth of the region.
The global organ transplantation market segmentation is done as per the following dynamics: type. End-users, products, and treatment.
By type, the market comprises of lungs, heart, liver, kidney, and others.
By products, the market segments into tissue products, organ preservation solutions, transplant diagnostics, and others.
By type of treatment, the market includes immunosuppressant, analgesic, and other. Immunosuppressant is narrowed down into mTOR inhibitor, calcineurin inhibitors, steroids, antiproliferative agents, and other. Whereas calcineurin inhibitors are divided into tacrolimus and cyclosporine. And, mTOR inhibitor is broken down into sirolimus and everolimus.
By type of transplant, the market includes allograft, xenograft, autograft, allotransplantation, xenotransplantation, and others.
By end users, the market comprises transplant centers, hospitals, and others.
Check Avail Discount on Report @ https://www.marketresearchfuture.com/check-discount/915
About Market Research Future:
Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.
We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.
Market Research Future (MRFR)
528, Amanora Chamber
Hadapsar, Pune – 411028
Phone: +1 646 845 9312